DataMeds AI, Inc. Common Stock

Day range

$2.14 – $2.29

Open

$2.24

Prev close

$2.23

Volume

525.48K

Market cap

$10.07M

Shares out

4.52M

• Listing deficiency noticeOct 20, 2026

  On April 13, 2026, the Company received a deficiency letter ... notifying the Company that ... the Company no longer satisfied the $2,500,000 minimum stockholders' equity requirement for continued listing on The Nasdaq Capital Market set forth in Nasdaq Listing Rule 5550(b)(1), and that ... the Company also did not meet the alternative compliance standards under that Rule.

• Listing deficiency noticeOct 16, 2026

  The Company received a deficiency letter ... notifying the Company that ... the Company no longer satisfied the $2,500,000 minimum stockholders' equity requirement for continued listing on The Nasdaq Capital Market set forth in Nasdaq Listing Rule 5550(b)(1).

• Licensing agreementOct 13, 2026

  On October 13, 2026, the Company entered into a license agreement with REBOOT Health AI, Inc. (“REBOOT”) pursuant to which the Company licensed a care management platform to integrate into its business model.

• Settlement agreementSep 17, 2026

  On September 11, 2026, DataMEDS AI, Inc. entered into a settlement agreement and release with Brian Norton and the other Settling Parties. Pursuant to the Agreement, the parties agreed to dismiss the litigation in Florida and Delaware with prejudice and to exchange mutual releases of claims.

• Acquisition completionSep 16, 2026

  On September 11, 2026, DataMeds AI, Inc. entered into a stock purchase agreement with Axe Compute Inc., pursuant to which the Company purchased from Seller all of the issued and outstanding shares of common stock of Helomics Corporation. The closing of the transactions contemplated by the Purchase Agreement occurred simultaneously with the execution and delivery of the Purchase Agreement on September 11, 2026, and Helomics became a wholly owned subsidiary of the Company.

Days to cover

1.0

Short interest

525.08K

Avg volume

22.5M

As of Sep 30, 2026 · reported to FINRA twice monthly.

• TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc.
  neutralGlobeNewswire Inc.· Sep 20, 2024
• TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
  GlobeNewswire Inc.· May 29, 2024
• Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
  Benzinga· Mar 11, 2024
• Nasdaq Gains 100 Points; Campbell Soup Earnings Top Views
  Benzinga· Mar 6, 2024
• Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
  Benzinga· Mar 6, 2024